Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Stores of glucose in the brain could play a much more significant role in the pathological degeneration of neurons than ...

Boosting the brain’s sugar-clearing switch cuts toxic buildup and may explain why fasting looks good for memory.

Scientists have discovered that the metabolism of glycogen, a sugar stored in neurons, can protect the brain from Alzheimer's disease and cognitive decline.

A new study from scientists at the Buck Institute for Research on Aging has revealed a surprising player in the battle ...

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...

Scientists have uncovered a surprising sugar-related mechanism inside brain cells that could transform how we fight Alzheimer’s and other dementias. It turns out neurons don’t just store sugar for ...

Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Pharmacy benefit leaders at Holmes Murphy share what to consider when evaluating GLP-1s for your ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...